NCT03460977 2026-03-13A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaPfizerPhase 1 Recruiting453 enrolled
NCT05546268 2026-03-03Study of Oral MRT-2359 in Selected Cancer PatientsMonte Rosa Therapeutics, IncPhase 1/2 Active not recruiting174 enrolled